Related Experiment Video
Updated: May 14, 2026
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Management Approach for Residual and Recurrent Mitral Regurgitation After Transcatheter Edge-to-Edge Repair
Jonathan X Fang1, Gennaro Giustino2, Kent Chak-Yu So3
1Center for Structural Heart Disease, Henry Ford Health System, Detroit, Michigan, USA.
JACC. Cardiovascular Interventions
|May 12, 2026
Summary
Transcatheter edge-to-edge repair (M-TEER) effectively treats severe mitral regurgitation (MR). However, some patients develop recurrent MR, requiring careful management strategies for this growing patient group.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Transcatheter edge-to-edge repair (M-TEER) is a key treatment for severe mitral regurgitation (MR) in high-risk surgical patients.
- A significant minority of patients (up to 10% at 1 year) experience recurrent or residual MR post-M-TEER.
- The increasing volume of M-TEER procedures leads to a rise in patients with challenging post-procedural MR.
Purpose of the Study:
- To review practical management strategies for patients with residual or recurrent severe MR after M-TEER.
- To address the complexities introduced by M-TEER in subsequent treatment options for MR.
- To provide guidance for clinicians managing this specific patient population.
Main Methods:
- Literature review focusing on management of post-M-TEER MR.
- Analysis of current treatment approaches and outcomes.
- Synthesis of expert considerations for clinical decision-making.
Main Results:
- M-TEER alters mitral valve anatomy, complicating re-intervention.
- Recurrent MR rates necessitate defined follow-up and management pathways.
- Various strategies exist for managing residual or recurrent MR, tailored to individual patient anatomy and severity.
Conclusions:
- Effective management of post-M-TEER MR is crucial due to increasing patient numbers.
- A multidisciplinary approach is often required for optimal outcomes.
- Further research into advanced techniques and long-term results is warranted.
Related Concept Videos
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:28Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:23Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...